Intensity-Modulated Radiotherapy Triggers Onset of Bullous Pemphigoid in a Patient with Advanced Melanoma Treated with Nivolumab

Since the efficacy of ipilimumab on nivolumab-resistant advanced melanoma is extremely low, additional supportive therapy for anti-PD-1 antibody therapy-resistant advanced melanoma is needed. Although several supportive therapies that enhance the antitumor immune response of anti-PD-1 antibodies hav...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Kayo Tanita, Taku Fujimura, Yumi Kambayashi, Akira Tsukada, Yota Sato, Akira Hashimoto, Setsuya Aiba
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Karger Publishers 2018-02-01
Serie:	Case Reports in Oncology
Soggetti:	Intensity-modulated radiotherapy Bullous pemphigoid Nivolumab Advanced melanoma
Accesso online:	https://www.karger.com/Article/FullText/487127
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!